levodopa has been researched along with Aprosodia in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (11.11) | 18.7374 |
1990's | 4 (11.11) | 18.2507 |
2000's | 9 (25.00) | 29.6817 |
2010's | 18 (50.00) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Dusek, P; Novotny, M; Rusz, J; Ruzicka, E; Sonka, K; Tykalova, T; Zogala, D | 1 |
Hara, K; Hattori, M; Kajita, Y; Katsuno, M; Kawabata, K; Maesawa, S; Nakatsubo, D; Ohdake, R; Sato, M; Sobue, G; Tanaka, Y; Tsuboi, T; Watanabe, H | 1 |
Bär, KJ; Brodoehl, S; Klingner, C; Mentzel, H | 1 |
Arnold, C; Gehrig, J; Gispert, S; Kell, CA; Seifried, C | 1 |
Čmejla, R; Klempíř, J; Roth, J; Rusz, J; Růžička, E; Růžičková, H; Tykalová, T | 1 |
Azevedo, LL; Cardoso, F; Oliveira, PM; Souza, IS | 1 |
Chiou, SM; Huang, HM; Lin, YC | 1 |
Elfmarková, N; Gajdoš, M; Mekyska, J; Mikl, M; Mračková, M; Rektorová, I | 1 |
Delooze, C; Ghio, A; Grigoli, C; Mas, M; Mercier, C; Robert, D; Viallet, F | 1 |
Čmejla, R; Klempíř, J; Rusz, J; Růžička, E; Tykalová, T | 1 |
Ak, F; Cakmakli, GY; Gulunay, A; Karakoc, M; Oztekin, N; Ulusoy, EK; Yon, MI | 1 |
Han, JH; Jeon, BS; Kim, C; Kim, DG; Lee, JY; Paek, SH | 1 |
Azulay, JP; Cantiniaux, S; Horrelou-Pitek, C; Mancini, J; Robert, D; Vaugoyeau, M; Witjas, T | 1 |
Boon, P; De Bodt, M; De Letter, M; Dhooge, I; Santens, P; Van Borsel, J | 1 |
Martnez-Sánchez, F | 1 |
Flasskamp, A; Schlegel, U; Skodda, S | 1 |
Burchiel, KJ; Carlson-Kuhta, P; Hogarth, P; Horak, FB; Robertson, LT; St George, RJ | 1 |
Bakheit, AM; Brennan, A; Fletcher, K | 1 |
Ben-Djebara, M; Gargouri, A; Gouider, R; Kacem, I | 1 |
Camargos, S; Cardoso, F; Lees, AJ; Singleton, A | 1 |
Coelho, C; Goberman, AM | 1 |
Balash, Y; Bartels, AL; Giladi, N; Gurevich, T; Hausdorff, JM; Schaafsma, JD | 1 |
Azevedo, LL; Cardoso, F; Reis, C | 1 |
Magnani, P; Mailland, E; Ottillinger, B | 1 |
Bradshaw, JL; Ho, AK; Iansek, R | 1 |
Critchley, EM | 2 |
Brennan, MJ; Sandyk, R | 1 |
Marsden, CD | 2 |
Hixon, TJ; Solomon, NP | 1 |
Bioulac, B; Boraud, T; Gross, C; Guehl, D; Julien, J; Rougier, A | 1 |
Cáceres, M; Costello, G; Herrera, EJ; Suárez, JC; Suárez, M; Viano, JC | 1 |
Fahn, S; Ford, B; Louis, ED; Winfield, L | 1 |
Altibrandi, MG; Brusa, L; Giacomini, P; Mazzone, P; Peppe, A; Pierantozzi, M; Stanzione, P | 1 |
Kaumeier, S | 1 |
7 review(s) available for levodopa and Aprosodia
Article | Year |
---|---|
[Speech and voice disorders in Parkinson's disease].
Topics: Antiparkinson Agents; Dysarthria; Humans; Levodopa; Parkinson Disease; Phonation; Speech Acoustics; Speech Disorders; Voice Disorders; Voice Quality | 2010 |
Clinical and single-photon emission computed tomography study of pure akinesia with freezing of gait.
Topics: Diagnosis, Differential; Dopamine Agents; Gait Apraxia; Humans; Levodopa; Male; Middle Aged; Morocco; Speech Disorders; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2012 |
Acoustic analysis of parkinsonian speech I: speech characteristics and L-Dopa therapy.
Topics: Articulation Disorders; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Long-Term Care; Male; Parkinson Disease; Prognosis; Risk Assessment; Risk Factors; Speech Acoustics; Speech Disorders; Speech Production Measurement; Speech Therapy; Treatment Outcome | 2002 |
Speech disorders of Parkinsonism: a review.
Topics: Humans; Levodopa; Parkinson Disease; Respiration; Speech; Speech Disorders; Stereotaxic Techniques; Thalamus | 1981 |
Parkinson's disease.
Topics: Cognition Disorders; Disabled Persons; Gait; Humans; Levodopa; Medical Audit; Movement Disorders; Neurocognitive Disorders; Neurosurgery; Parkinson Disease; Postural Balance; Practice Guidelines as Topic; Speech Disorders | 1994 |
Speech breathing in Parkinson's disease.
Topics: Adult; Aged; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Respiration; Speech; Speech Disorders; Speech Perception; Speech Production Measurement | 1993 |
Problems with long-term levodopa therapy for Parkinson's disease.
Topics: Cognition Disorders; Dyskinesia, Drug-Induced; Gait; Humans; Levodopa; Parkinson Disease; Speech Disorders; Time Factors | 1994 |
3 trial(s) available for levodopa and Aprosodia
Article | Year |
---|---|
Site of deep brain stimulation and jaw velocity in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Combined Modality Therapy; Deep Brain Stimulation; Deglutition Disorders; Double-Blind Method; Female; Globus Pallidus; Humans; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders; Subthalamic Nucleus; Treatment Outcome | 2011 |
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor | 2004 |
Posteroventral pallidotomy in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dyskinesias; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders; Treatment Outcome | 2000 |
26 other study(ies) available for levodopa and Aprosodia
Article | Year |
---|---|
Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy.
Topics: Dysarthria; Female; Humans; Levodopa; Parkinson Disease; Speech; Speech Disorders | 2021 |
Clinical correlates of repetitive speech disorders in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition; Dyskinesias; Female; Humans; Levodopa; Male; Memory; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Sex Factors; Speech Disorders; Speech Production Measurement; Stroop Test; Verbal Behavior | 2019 |
Transcortical motor aphasia and unilateral parkinsonism in a case of hyperostosis frontalis.
Topics: Aged; Antiparkinson Agents; Aphasia, Broca; Dopamine Antagonists; Female; Functional Laterality; Handwriting; Humans; Hyperostosis Frontalis Interna; Levodopa; Magnetic Resonance Imaging; Parkinsonian Disorders; Speech Disorders; Tiapride Hydrochloride | 2013 |
Pathomechanisms and compensatory efforts related to Parkinsonian speech.
Topics: Aged; Antiparkinson Agents; Biofeedback, Psychology; Brain; Female; Humans; Image Processing, Computer-Assisted; Levodopa; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Parkinson Disease; Psychoacoustics; Reading; Speech Disorders; Voice Disorders | 2014 |
Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study.
Topics: Adult; Aged; Dopamine Agents; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech; Speech Acoustics; Speech Disorders | 2015 |
Effect of speech therapy and pharmacological treatment in prosody of parkinsonians.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Acoustics; Speech Disorders; Speech Therapy; Treatment Outcome | 2015 |
One-year Outcome of Bilateral Subthalamic Stimulation in Parkinson Disease: An Eastern Experience.
Topics: Adult; Aged; Antiparkinson Agents; Cohort Studies; Deep Brain Stimulation; Disease Progression; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neurosurgical Procedures; Parkinson Disease; Postoperative Complications; Retrospective Studies; Speech Disorders; Subthalamic Nucleus; Taiwan; Treatment Outcome | 2015 |
Impact of Parkinson's disease and levodopa on resting state functional connectivity related to speech prosody control.
Topics: Aged; Brain; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Neural Pathways; Parkinson Disease; Rest; Speech; Speech Disorders | 2016 |
[F0 characteristics in Parkinsonian speech: Contrast between the effect of hypodopaminergy due to Parkinson's disease and that of the therapeutic delivery of L-Dopa].
Topics: Case-Control Studies; Dopamine Agents; Female; Humans; Levodopa; Male; Parkinson Disease; Phonation; Speech Acoustics; Speech Disorders; Treatment Outcome | 2014 |
Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
Topics: Adult; Aged; Antiparkinson Agents; Female; Follow-Up Studies; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Speech Disorders | 2016 |
Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Freezing Reaction, Cataleptic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Sialorrhea; Speech Disorders; Statistics, Nonparametric; Surveys and Questionnaires | 2016 |
Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Topics: Adult; Aged; Antiparkinson Agents; Deep Brain Stimulation; Electrodes, Implanted; Female; Functional Laterality; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Speech Disorders; Subthalamic Nucleus; Treatment Outcome | 2008 |
Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech; Speech Disorders; Walking | 2010 |
Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Speech; Speech Disorders | 2010 |
Instability of syllable repetition in Parkinson's disease--influence of levodopa and deep brain stimulation.
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Deep Brain Stimulation; Disability Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Speech Disorders | 2011 |
Successful treatment of severe abulia with co-beneldopa.
Topics: Benserazide; Cranial Fossa, Posterior; Dopamine Agents; Drug Combinations; Female; Humans; Hydrocephalus; Levodopa; Meningeal Neoplasms; Meningioma; Middle Aged; Psychomotor Disorders; Speech Disorders | 2011 |
DYT16: the original cases.
Topics: Adolescent; Adult; Age of Onset; Anti-Dyskinesia Agents; Antiparkinson Agents; Baclofen; Biperiden; Botulinum Toxins; Carbidopa; Child; Child, Preschool; Cholinergic Antagonists; Drug Combinations; Drug Resistance; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Male; Middle Aged; Muscle Relaxants, Central; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; RNA-Binding Proteins; Speech Disorders; Trihexyphenidyl; Young Adult | 2012 |
Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
Topics: Antiparkinson Agents; Gait Ataxia; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Motor Activity; Movement Disorders; Parkinson Disease; Postural Balance; Speech Disorders; Tremor | 2003 |
[Acoustic analysis of prosody in females with Parkinson's disease: effect of L-dopa].
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Female; Humans; Language; Levodopa; Middle Aged; Parkinson Disease; Phonation; Sound Spectrography; Speech Acoustics; Speech Disorders; Speech Production Measurement; Voice Quality | 2003 |
For better or worse: The effect of levodopa on speech in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech; Speech Disorders; Verbal Behavior; Voice Disorders | 2008 |
Impairment of somatosensory feedback control of the tongue in Parkinson's disease: effect of L-Dopa therapy.
Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders; Tongue | 1982 |
High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases.
Topics: Adult; Disease Progression; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes, Implanted; Follow-Up Studies; Gait; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Stereotaxic Techniques; Thalamic Nuclei; Treatment Outcome; Tremor | 1997 |
Speech dysfluency exacerbated by levodopa in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Speech Disorders; Stuttering; Videotape Recording | 2001 |
Deep brain stimulation (DBS) attentional effects parallel those of l-dopa treatment.
Topics: Adult; Attention; Cognition; Electric Stimulation Therapy; Globus Pallidus; Humans; Levodopa; Middle Aged; Neuropsychological Tests; Parkinson Disease; Speech Disorders; Subthalamic Nucleus | 2001 |
[Parkinsonism].
Topics: Amantadine; Arteriosclerosis; Genes, Dominant; Guam; Histamine H1 Antagonists; Humans; Levodopa; Middle Aged; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Physical Therapy Modalities; Speech Disorders | 1978 |
Letter: Peak-dose dysphonia in parkinsonism.
Topics: Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders | 1976 |